We asked Dr Burns what makes Amplia such a unique and exciting company:
“My connection to Amplia precedes the formation of the company. I have been interested in FAK as a promising target for anticancer drugs for some time, and published work by SAB member Prof. Margaret Frame and others, showing how FAK inhibition can enhance the effect of approved cancer drugs, galvanised my desire to develop the promising FAK inhibitors discovered at the CRC for Cancer Therapeutics.
So in 2016 I helped found Amplia Therapeutics, and have been a Director of the Company since 2018.
I was involved in the early development of AMP945 and AMP886, helping to establish stable and developable forms of these unique drugs.
We live in a golden age of science and technology, and rigorous R&D is imperative. Amplia has always been driven by quality science and a pursuit of doing drug discovery and development the right way. We are committed to conducting our work to the highest quality and safety standards.
I am delighted to be guiding the Company into its next phase of development as CEO. Not only are we developing best-in-class FAK inhibitors with enormous clinical potential, but we have an A-grade team of talented individuals who work openly and collaboratively, both internally and with our partners and contractors.”
Exciting times ahead ...
.
- Forums
- ASX - By Stock
- New CEO Dr Chris Burns
We asked Dr Burns what makes Amplia such a unique and exciting...
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATX (ASX) to my watchlist
|
|||||
Last
12.5¢ |
Change
-0.005(3.85%) |
Mkt cap ! $34.27M |
Open | High | Low | Value | Volume |
13.0¢ | 13.0¢ | 12.0¢ | $120.7K | 983.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 279677 | 12.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
12.5¢ | 16317 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 229677 | 0.120 |
2 | 349506 | 0.115 |
3 | 33787 | 0.110 |
5 | 289600 | 0.105 |
13 | 487000 | 0.100 |
Price($) | Vol. | No. |
---|---|---|
0.125 | 16317 | 1 |
0.130 | 82439 | 1 |
0.135 | 25000 | 1 |
0.140 | 132730 | 3 |
0.145 | 120000 | 3 |
Last trade - 15.44pm 23/08/2024 (20 minute delay) ? |
Featured News
ATX (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online